Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Acute Suicidal Ideation and Behavior: The SBD-ASIB Study

NCT03396068 is registered in ClinicalTrials.gov with NeuroRx, Inc. as lead sponsor.

NCT NCT03396068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Acute Suicidal Ideation and Behavior: The SBD-ASIB Study
Lead sponsor
NeuroRx, Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
December 1, 2019
Completion date
December 31, 2024
Enrollment
72 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, suicidal ideation